drugset / Trial / NCT00954707

CYPRESS - CYPHER for Evaluating Sustained Safety

NCT00954707

Phase 4 Unknown 2509 enrolled Cordis US Corp.
RandomizedParallel-groupTriple-blindTreatment

Summary

CYPRESS: A Prospective,Randomized,Multi-Center,Double-Blind Trial to Assess the Effectiveness and Safety of Different Durations of Dual Anti-Platelet Therapy (DAPT) in Subjects Undergoing Percutaneous Coronary Intervention with the CYPHER® Sirolimus-eluting Coronary Stent (CYPHER® Stent)

Timeline

Start
2009-08
Primary completion
2012-01
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clopidogrel Small molecule
Comparator Prasugrel Small molecule
Comparator Aspirin Small molecule